The basics on the prevalence, epidemiology, and public health impact of Herpes Simplex Virus.

Prevalence, Demographics, and Data on Herpes Simplex Virus

2018 NCHS Data Brief: Prevalence of Herpes Simplex Virus Type 1 and Type 2 in
Persons Aged 14–49: United States, 2015–2016

National STD Training Curriculum on Herpes from NSTDC

Association with HIV/AIDS

Why Genital Herpes boosts the risk of HIV infection

Management of Herpes Simplex Virus Type 2 Infection in HIV Type 1–Infected Persons

WHO Report: The risk of HIV acquisition is approximately tripled

Herpes and Neurodegenerative Disease

The Encephalitis Center at Johns Hopkins

UCSF Center for Encephalitis and Meningitis

How an increase in the copy number of HSV-1 during latency can cause Alzheimer’s disease: the viral and cellular dynamics according to the microcompetition model

Neurological Complications of Herpes Simplex Virus Type 2 Infection

The neurotropic herpes viruses: herpes simplex and varicella-zoster

Herpes Simplex Virus Type 1 Infection of the Central Nervous System: Insights Into Proposed Interrelationships With Neurodegenerative Disorders

Public Health Guidelines for Herpes

2021 CDC STI Treatment Guidelines and guidance on Herpes Screening

Reports on Herpes Simplex Virus

WHO Preferred Product Characteristics for Herpes Simplex Virus Vaccines

National Academy of Science Engineering and Medicine 2021 STI REPORT

US Department of Health and Human Services 2020 HSV STI Report

Performance of Herpes Tests

Performance of Commercial Enzyme-Linked Immunoassays for Diagnosis of Herpes Simplex Virus-1 and Herpes Simplex Virus-2 Infection in a Clinical Setting (2017)

Herpes simplex virus type 2 (HSV-2) IgG index values in two immunoassays in relation to HSV-2 IgG inhibition assay results (2019)

Characterization of Serum Samples With Discordant Results in 2 Herpes Simplex Virus Type 2 IgG Assays 2022